Danqi Qian
Wuxi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Integrative pan-cancer and COAD-focused multi-omics analysis of non-histone acetylation substrate-related transcriptional landscapes.
Journal: NPJ precision oncology
Published: April 11, 2026
Reprogramming Tumor-Associated Macrophages via Targeted NAT10 Inhibition to Enhance Colorectal Cancer Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 25, 2025
Hsa_circ_0049271 Facilitates Esophageal Squamous Cell Carcinoma Progression and Cisplatin Resistance by Enhancing Cellular Senescence via miR-455-5p/ETS1.
Journal: Journal of biochemical and molecular toxicology
Published: May 09, 2025
Mixed radiation with different doses induces CCL17 to recruit CD8+T cell to exert anti-tumor effects in non-small cell lung cancer.
Journal: Frontiers in immunology
Published: October 08, 2024
Comprehensive malnutritional index for predicting clinical outcomes in locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.
Journal: Biomolecules & biomedicine
Published: August 26, 2024
Predictive and prognostic value of preoperative pan-immune-inflammation value in patients with locally advanced rectal cancer.
Journal: Biomolecules & biomedicine
Published: April 24, 2024
Association of preoperative muscle-adipose index measured by computed tomography with survival in patients with esophageal squamous cell carcinoma.
Journal: World journal of surgical oncology
Published: November 21, 2023
Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma.
Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma.
Journal: Frontiers in immunology
Published: November 07, 2023
CT imaging-based radiomics signatures improve prognosis prediction in postoperative colorectal cancer.
Journal: Journal of X-ray science and technology
Published: August 28, 2023
IRF7 and IFIT2 in mediating different hemorrhage outcomes for non-small cell lung cancer after bevacizumab treatment.
Journal: Journal of thoracic disease
Published: February 15, 2023
Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer.
Journal: Oncology letters
Published: July 21, 2019
Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma.
Journal: OncoTargets and therapy
Published: December 22, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026